Holliston

The chief financial officer of Holliston-based Harvard Bioscience has resigned shortly after the company reported record second quarter revenue.

Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.

Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.

Holliston medical device maker Harvard Bioscience is hoping to get out of the red as its second quarter revenues of $31.5 million reached an all-time high.

The Hendler brothers have quickly become giants in the beer-making industry, running the second largest Central Massachusetts brewery at 44,250 barrels produced in 2017.

The owner of a Fitchburg private wastewater treatment company and an engineering company has been sentenced to three years of probation and other penalties for falsifying wastewater supplies and test results.

A Harvard Bioscience subsidiary has launched a new inhalation and exposure system for drug research amid rising popularity of drugs taken respiratorily.

Northborough pizza chain Bertucci's has been bought at bankruptcy auction for a deal worth up to $20 million.

A California medical cannabis real estate firm has purchased the site of a proposed cultivation facility in Holliston for $3 million.

A former Bank of America executive who helped the company secure millions in foreign investments has been named the new president of Biostage in Holliston.